The Left Atrial Appendage: a Silent Threat
ENDOSCOPIC CLOSURE OF LEFT ATRIAL APPENDAGE
Mr Dincer Aktuerk, Clinical Lead for Robotic and Minimally Invasive Cardiac Surgery at Barts Heart Centre, will discuss your options and help you determine the best course of action for your specific situation.
Atrial fibrillation is a heart rhythm disorder that causes the upper chambers of the heart (atria) to beat irregularly and quiver instead of contracting normally. This irregular heartbeat can cause blood to pool in the left atrial appendage (LAA), a small pouch in the left atrium. The pooled blood can form clots, which can then travel to the brain and cause a stroke. LAAC closes off the LAA to prevent blood clots from forming there and traveling to the brain.
There are the two main options for closure of the LAA:
The Watchman device is a small, removable, parachute-shaped implant inserted through a catheter into the LAA during a minimally invasive procedure.
It acts like a plug, effectively blocking off the LAA and preventing blood clots from forming there and traveling to the brain, causing a stroke.
The procedure is usually performed by a cardiologist specialising in electrophysiology. The WATCHMAN device is usually the first choice and surgery reserved for cases where a WATCHMAN device was deemed not anatomically feasible or for patients who need heart surgery for other cardiac problems.
A small, permanent, clip-like device is used in a minimally invasive surgical procedure. It’s positioned around the base of the LAA, effectively sealing it off from the rest of the left atrium.
This reduces the risk of blood clots forming in the LAA and traveling to the brain, causing a stroke.
The LAAC procedure is performed while you’re completely asleep under general anaesthesia. Dincer will first make a small incision between the ribs on the left-hand side of your chest. He will then insert a thin camera (endoscope) and surgical instruments through the incision to perform the operation. The camera allows Dincer to see a three-dimensional image of your heart on a monitor in the operating room.
Next, the LAAC device, a small device resembling a tiny clothespin, is passed through the incision, and positioned around the base of the LAA. Once in place, the clip is closed, effectively sealing off the LAA from the rest of the left atrium. Finally, the instruments are removed, and the incision is closed with stitches.
Minimally invasive closure of the LAA offers several advantages for stroke prevention in patients with atrial fibrillation (AFib). Here are some key benefits:
Faster Recovery:
This is a major benefit. Because the procedure is minimally invasive, you can expect to feel better and resume most normal activities much sooner. Recovery typically takes around two to three weeks, compared to a longer recovery time associated with open-heart surgery.
Reduced Pain:
Minimally invasive surgery results in less post-operative discomfort and pain. The smaller incision translates to less tissue disruption and faster healing.
Shorter Hospital Stay:
Generally, patients undergoing minimally invasive LAA closure require a shorter hospital stay, typically 2-3 days compared to a longer stay needed for open-heart surgery.
Lower Infection Risk:
There’s a reduced risk of developing wound infections with the smaller incision used in minimally invasive surgery. This is because there’s less exposure to the environment and less tissue disruption.
Improved Cosmetic Outcome:
The smaller incision used in minimally invasive surgery typically results in a much better cosmetic outcome with a less noticeable scar. This can be a significant benefit for some patients.
Potential Elimination of Blood Thinners:
A major advantage following LAAC is the possibility of eliminating the need for long-term blood thinners. Blood thinners, while effective in preventing blood clots, can increase the risk of bleeding. However, it’s important to discuss this possibility with your cardiologist, as individual circumstances may influence this decision.
What is the left atrial appendage and why is it important?
The left atrial appendage (LAA) is a small pouch in the wall of the left atrium – one of the upper chambers of the heart. In patients with atrial fibrillation, blood can pool and form clots in the LAA because the chaotic rhythm prevents normal atrial contraction. These clots can break loose and travel to the brain, causing a stroke. Studies suggest that the LAA is the source of more than 90 per cent of AF-related strokes.
What does endoscopic closure of the left atrial appendage involve?
Endoscopic LAA closure is a minimally invasive surgical procedure in which Mr Dincer Aktuerk uses small incisions and a camera (endoscope) to access and close off the appendage from the outside of the heart, typically using a clip or stapler. By sealing the appendage, the risk of clot formation and stroke is significantly reduced. The procedure is most commonly performed at the same time as another planned cardiac operation, such as mitral valve repair or AF surgery.
How is surgical LAA closure different from the Watchman device?
The Watchman (and similar devices) is an endovascular option that can be inserted via a catheter through the groin, without surgery. Surgical LAA closure – particularly ligation or stapling performed during a cardiac operation – has the advantage of providing complete, confirmed closure of the appendage, verified directly by the surgeon. Studies suggest that incomplete closure (a recognised issue with some catheter-based approaches) may still carry stroke risk, whereas surgical closure eliminates the appendage fully.
Who should consider LAA closure?
LAA closure is particularly beneficial for patients with AF who are at high risk of stroke but unable to tolerate long-term anticoagulation; for example, due to previous bleeding, a high fall risk, or occupation-related concerns. It is also strongly recommended for patients undergoing cardiac surgery for another reason, as it can be completed with minimal additional risk during the same operation.
Will I still need blood thinners after LAA closure?
This depends on your individual stroke risk profile and whether you continue to have AF. LAA closure reduces but does not eliminate stroke risk entirely – other mechanisms of embolism exist. Your cardiologist will review your CHA₂DS₂-VASc score and advise whether anticoagulation can be safely discontinued. Many patients can reduce or stop anticoagulants after successful closure is confirmed.
Is endoscopic LAA closure safe?
When performed by an experienced cardiac surgeon, endoscopic LAA closure has a well-established safety profile. When combined with another planned cardiac procedure, it adds minimal additional time and risk to the operation. As a standalone procedure, the risk is low, and the potential long-term benefit in stroke risk reduction is significant for the right patients.
The best option for you will depend on several factors, including your overall health and suitability for minimally invasive procedures and your risk of stroke due to AFib. Dincer will also take into account wether you’re undergoing other open-heart surgery and your preference for a removable device vs permanent closure.